Back
Organogenesis Holdings 10K Form
Buy
54
ORGO
Organogenesis Holdings
Last Price:
2.50
Seasonality Move:
6.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | ORGO/Organogenesis Holdings Quarterly |
| 2020-05-11 | 10Q | ORGO/Organogenesis Holdings Quarterly |
| 2020-04-29 | 10K | ORGO/Organogenesis Holdings Annual |
| 2020-03-09 | 10K | ORGO/Organogenesis Holdings Annual |
| 2019-11-12 | 10Q | ORGO/Organogenesis Holdings Quarterly |
| 2019-08-09 | 10Q | ORGO/Organogenesis Holdings Quarterly |
Receive ORGO News And Ratings
See the #1 stock for the next 7 days that we like better than ORGO
ORGO Financial Statistics
Sales & Book Value
| Annual Sales: | $433.14M |
|---|---|
| Cash Flow: | $7.29M |
| Price / Cash Flow: | 50.36 |
| Annual Sales: | $2.12 |
| Price / Book: | 1.18 |
Profitability
| EPS (TTM): | 0.03570 |
|---|---|
| Net Income (TTM): | $4.95M |
| Gross Margin: | $326.66M |
| Return on Equity: | 1.82% |
| Return on Assets: | 1.09% |
Organogenesis Holdings Earnings Forecast
Key Organogenesis Holdings Financial Ratios
- The Gross Profit Margin over the past 8 years for ORGO is 75.42%.
- The Selling, General & Administrative Expenses for ORGO have been equal to 62.28% of Gross Profit Margin.
- The Research & Development expenses have been 10.25% of Revenue.
- The Interest Expense is 44.29% of Operating Income.
- The Net Earning history of ORGO is 1.14% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 4 years.
Organogenesis Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ORGO |
| CUSIP: | 68621F |
| Website: | organogenesis.com |
Debt
| Debt-to-Equity Ratio: | 0.24 |
|---|---|
| Current Ratio: | 2.8 |
| Quick Ratio: | 2.31 |
Price-to-Earnings
| Trailing P/E Ratio: | 62.25 |
|---|---|
| Forward P/E Ratio: | 16.6 |
ORGO Technical Analysis vs Fundamental Analysis
Buy
54
Organogenesis Holdings (ORGO)
is a Buy
Is Organogenesis Holdings a Buy or a Sell?
-
Organogenesis Holdings stock is rated a Buy
The current Organogenesis Holdings [ORGO] share price is $2.49. The Score for ORGO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.